Table S7 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial
Year: 2024
Type: other
Abstract: Table S7 shows Serious Adverse Events (N = 11 patients), by Type and Grade. Attributions Assigned Docetaxel versus HDIVC or Placebo
Authors: Channing J. Paller, Marianna L. Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth Heath, William K. Kelly, Christopher Hoimes, Pedro Barata, Jason Taksey, Dominique A. Garrison, Kartick Patra, Ginger L. Milne, Nicole M. Anders, Julie M. Nauroth, Jennifer N. Durham, Catherine H. Marshall, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Michael A. Carducci, Samuel R. Denmeade, Mark Levine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4402848345